Clinical Trial Update: IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial (IN10018) evaluating IN10018 in combination with standard chemotherapy for high-grade serous epithelial ovarian cancer is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Serous Ovarian Cancer
• Ovarian Cancer
• Platinum-resistant Ovarian Cancer

Drugs mentioned

• IN10018

Snippet

Sponsor: InxMed (Shanghai) Co., Ltd. | Conditions: Platinum-resistant Ovarian Cancer | Phase 1, Phase 2 | Status: RECRUITING